Insulin Enhances NF-κB Activation in Luminal A T -47D Breast Cancer Cells Exposed to Low-Dose Doxorubicin
Findings indicate that insulin increases NF-κB activation in doxorubicin -treated T-47D breast cancer cells and may sustain NF-κB activity against the cytotoxic effects of doxorubicin.